Alendronate/lactoferrin-dual decorated lipid nanocarriers for bone-homing and active targeting of ivermectin and methyl dihydrojasmonate for leukemia
Chronic myeloid leukemia is a hematological cancer, where disease relapse and drug
resistance are caused by bone-hosted-residual leukemia cells. An innovative resolution is …
resistance are caused by bone-hosted-residual leukemia cells. An innovative resolution is …